Sheba Introduces Innovative Drug Delivery System for Advanced Parkinson’s Treatment

This new drug delivery system involves a subcutaneous pump that administers a continuous dose of medication, thus enhancing symptom management for patients suffering from this debilitating condition.

Revolutionary Technology in Parkinson’s Care

This new treatment method addresses one of the major challenges faced by Parkinson’s patients: the difficulty in maintaining a consistent level of medication in the bloodstream. Traditionally, patients rely on oral medication such as L-Dopa, which requires precise timing and increasingly higher doses over time to combat symptoms such as tremors, rigidity, slow movements, pain, anxiety, and difficulties with walking, speaking, and eating. However, the effectiveness of oral medication diminishes over time, necessitating frequent adjustments and leading to periods where the medication’s impact wanes.

The new system involves a pump that delivers medication continuously through a needle placed under the skin. This approach mimics advanced diabetes treatment devices, ensuring a steady, controlled release of the drug. As a result, patients experience fewer fluctuations in symptom control, leading to a significant improvement in their quality of life.

Expert Insights and Implementation

Dr.  Tsviya Fay-Karmon, a neurology specialist at Sheba and the director of the advanced Parkinson’s treatment program, emphasizes the transformative impact of this technology. “The pump stabilizes patients’ conditions, allowing them to maintain their daily activities without the frequent fluctuations caused by oral medications,” Dr. Fay-Karmon explains. “This is especially beneficial for patients with significant on-off fluctuations in their symptoms.”

The pump is designed to be worn on the patient’s body and administers a consistent dosage through a subcutaneous needle. This method not only reduces the occurrence of excessive movement side effects but also eliminates the gaps in medication effectiveness, known as “off” periods, which patients typically experience with oral medications.

Patient Testimonials and Outcomes

Ron Miron, a 49-year-old patient from Kadima-Zoran who has been diagnosed with Parkinson’s since 2019, shares his positive experience with the new treatment. “Before, I had to take pills several times a day and still experienced symptoms. Now, with this pump, I feel balanced all the time and can enjoy activities without worrying about my next dose,” Miron says. “This technology has given me the freedom to leave the house and participate in family activities without constantly being reminded of my condition.”

Dr. Fay-Karmon highlights another patient’s experience, where the patient’s spouse noted a significant improvement in their partner’s independence and mobility. “His wife told us that during a walk in Tel Aviv, she didn’t have to constantly watch over him for the first time in years,” Dr. Fay-Karmon recalls. “This kind of feedback underscores the profound impact this technology can have on patients’ lives.”